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Abstract
Objectives: The aim of the current study was to determine the effects of education with targeted or sham
exercise on pain and function in postmenopausal women with greater trochanteric pain syndrome (GTPS).
Background: Conservative management of GTPS is poorly described, and to date, there have been no studies
on education with exercise as an intervention for GTPS. Ninety-four postmenopausal women with GTPS were
recruited to participate in this study.
Materials and Methods: Participants were randomized to receive one of two 12-week exercise programs
(GLoBE vs. sham). Participants received education on avoiding tendon compression with appropriate activity
modification. The Victorian Institute of Sport Assessment-Gluteal tendon (VISA-G) was examined at baseline,
12, and 52 weeks. Secondary outcomes included hip pain and function questionnaires (Hip dysfunction and
Osteoarthritis Outcome Score (HOOS), Oxford Hip Score (OHS), and Lateral Hip Pain questionnaire), a global
rating of change in symptom questionnaire, and a quality of life measure (Assessment of Quality of Life
[AQoL]-8D). Differences between groups were analyzed using intention to treat with analysis of covariance,
per-protocol analysis, and responder analysis.
Results: Responders to the GLoBE intervention had significantly better VISA-G, HOOS, OHS, and lateral hip
pain questionnaire scores compared to responders in the sham group. However, intention to treat analyses
showed no between-group differences for the GLoBE intervention and sham exercise groups. Significant
improvement in VISA-G score was found for both programs at 12- and 52-weeks time points ( p< 0.001).
Conclusion: Lack of treatment effect was found with the addition of an exercise program to a comprehensive
education on GTPS management. The improved outcomes of the responders in the GLoBE group indicate that
there may be a subgroup of patients with a GTPS diagnosis that benefit from a GLoBE intervention program.
Keywords: postmenopausal, women, tendinopathy, GTPS, exercise, rehabilitation
Introduction
Greater trochanteric pain syndrome (GTPS) is acommon complaint in primary healthcare, particularly
in women aged between 45 and 63 years.1 The condition
involves pathology of the gluteus medius and minimus ten-
dons (gluteal tendinopathy) and/or trochanteric bursa (tro-
chanteric bursitis).2–5 Those with the condition commonly
describe intermittent or continuous pain at, or around, the
greater trochanter of the femur while sitting, stair climbing,
walking, and lying on their side.6 GTPS has negative impli-
cations on employment and quality of life, which mimic that
experienced by people with severe hip osteoarthritis (OA)
awaiting hip arthroplasty.7 The reported incidence of GTPS
is 1.8 per 1000 patients per year in primary care,1 and the
prevalence rate of GTPS is 23.5% in women at risk of knee
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OA8 and 54% in recipients of renal transplants.9 In com-
parison, the prevalence of hip OA is 26% in females over
55 years.10
The conservative management of GTPS is poorly de-
scribed, despite the plethora of studies on injection therapy,
shockwave, and surgical interventions for the lateral hip re-
gion.11 To date, there have been no studies on education as an
intervention for GTPS, and study by Rompe et al.12 is the
only study to investigate the use of an exercise program for
the management of GTPS. Rompe et al.12 compared exercise
therapy with corticosteroid injection and shock wave therapy
and found that exercise therapy was less effective for self-
reported pain and recovery levels than corticosteroid injec-
tion at 1 month follow-up, but was superior at the 15-month
follow-up, indicating longer-term benefits. It is possible that
in the short term, some exercises used by Rompe et al.12
(piriformis and iliotibial band stretching) may have aggra-
vated the condition by increasing tendinous compression, and
by the 15-month follow-up, participants had stopped com-
pleting potentially provocative exercises. This limitation will
be addressed in the current study using GLoBE exercise and
education on posture and activity modification, to reduce
compression of the gluteal tendons.
Since exercise has been reported to be the best intervention
for other lower limb tendons (Achilles13 and patellar tendi-
nopathy14), a similar treatment algorithm for the gluteal
tendons may be effective in reducing pain and dysfunction.
Both eccentric and heavy slow resistance exercise have been
shown to be beneficial15,16 for rehabilitating tendon condi-
tions. More recently, isometric contractions have been re-
ported to target both peripheral and central pain drivers by
releasing cortical inhibition and reducing tendon pain im-
mediately and for 45 minutes postintervention in the labo-
ratory17 and during in-season training in those suffering with
patellar tendinopathy.18 The effect of exercise on pain or
dysfunction associated with GTPS requires investigation.
The aim of the current study was to determine the effects of
education with targeted or sham exercise on pain and func-
tion in postmenopausal women with GTPS.
Materials and Methods
Design
This was a participant-blinded, single-arm randomized
controlled trial (RCT) with 12-week (primary outcome time
point) and 52-week follow-up. Clinical assessment of par-
ticipants was undertaken at La Trobe University, Melbourne,
Australia. The trial received ethical approval from the La
Trobe University Human Ethics Committee (14-055). All
participants provided written informed consent.
This study was a component of a larger 2 · 2 factorial RCT
registered on the Australian New Zealand Clinical Trial
Registry (ACTRN12614001157662).19 That larger study in-
volved education, exercise, andmenopausal hormone therapy
interventions. Participants whowere not eligible for the larger
2 · 2 trial or not willing to participate due to the use of hor-
mone therapy participated in this single-arm trial.
Participants
Study participants were recruited from Victorian (Aus-
tralia) gymnasiums, local medical and allied health profes-
sional clinics, pharmacies, community noticeboards, sporting
clubs, as well as women’s associations and via social media.
Participants had to be postmenopausal (>52 weeks of men-
strual cessation), have lateral hip pain reproduction in three of
five pain provocation tests,20 and have sufficient English
skills to read and complete the questionnaires and consent to
the requirements of the study. If both hips were symptomatic,
the most painful side (as reported by the participant) was
evaluated in the study.
Participants were excluded if they had an injection into the
hip region in the previous 12 weeks (platelet-rich plasma,
autologous blood injection, or corticosteroid injection), a
history of hip trauma or surgery on the affected side, or any
other musculoskeletal, neurological, and cardiorespiratory
condition/s affecting their ability to participate in the study.
Randomization and blinding
Participants were randomized into either an intervention
group (GLoBE:Gluteal La TrobeUniversity exercise program)
or a control group (sham exercise). A block randomization
schedule was generated using a web-based randomization
program (www.randomisation.com) by an external investi-
gator, who had no contact with participants throughout the
duration of the trial. The external researcher directly com-
municated to the treating physiotherapist implementing the
exercise intervention. Participants were blinded to group al-
location, but were aware that education was consistent across
the groups. Success of blinding was measured 1 week after
randomization. Data analysts and outcome measure assessors
were blinded to group allocation. Due to the nature of the
interventions, physiotherapists could not be blinded to the
treatment group so were trained to ensure equal provision of
care and motivation for both groups.
Education
An education booklet was provided to all participants. It
detailed activities to avoid (climbing stairs, walking up hills,
and hip adduction across midline) and correct sitting (hips
positioned higher than knees, no crossing legs), standing
(equal weight-bearing through lower limbs), and lying pos-
tures (no side lying) to reduce compressive tendon load.
Participants were instructed during the first physiotherapy
visit and throughout the trial to apply these principles to all
activities of daily living, recreation, and sport.
Interventions
The intervention was implemented by 23 physiotherapists
registered with the Australian Health Practitioner Regulation
Agency (AHPRA) with a minimum of 2 years’ musculo-
skeletal experience. Physiotherapists were provided 3 hours
of standardized training by the primary author in the exercise
and education protocols, incorporating theory and practical
sessions. Participants undertook a 10–15 minute home ex-
ercise program twice daily for 12 weeks. The exercise pro-
gram was initiated by a physiotherapist then reviewed and
progressed at 4, 8, and 12 weeks. Participants were asked to
refrain from undertaking any other treatment on their affected
hip (e.g., massage and acupuncture), but were encouraged to
maintain their normal non-aggravating activities. The par-
ticipants were asked not to have any injections into the hip for
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the duration of the treatment intervention (12 weeks). No
restriction on use of oral or topical anti-inflammatories or
analgesia and ice/heat was implemented.
GLoBE exercise protocol
Participants received a four-stage exercise program, in-
volving isometric loading of the gluteus medius and mini-
mus, and kinetic chain (quadriceps and calf muscle)
strengthening exercises (Fig. 1). Stage 1 commenced with an
isometric hip hitch hold (up to 40 seconds) in standing,
whereby the participant, holding onto a wall or chair for
balance, hitched their unaffected leg up off the ground
(*1 cm) while keeping both knees in full extension, loading
the contralateral/affected gluteal tendons without compres-
sion. In stages 2 and 3, the hip hitch was integrated with a
dynamic movement progression, adding toe taps and then hip
swings, respectively. The most advanced exercise in the
gluteal series was a single leg wall squat (stage 4). Quad-
riceps strengthening commenced with a double leg 1⁄4 –½
squat (stage 1), sit to stand exercise with feet even, and
progression to split stance variation (stage 2 and 3) and step-
ups (stage 4). Calf strengthening involved double leg calf
raises (stage 1), calf raises with toe taps (stage 2), and pro-
gressed onto single leg calf raises (stage 3 and 4). Participants
were instructed to complete 2–4 sets of 5–15 repetitions of
the prescribed dynamic exercises, depending on the indi-
vidual participants’ level of function and stage of the program
(see Supplementary Data; Supplementary Data are available
online at www.liebertpub.com/jwh for exercise booklet and
trial registry ACTRN12614001157662 for full dosage in-
structions and specific criteria to determine when the subjects
were ready to progress to the next stage of the program).
Sham exercise protocol
Participants received a four-stage sham exercise program
(Fig. 2) that predominately involved seated exercises not
aimed at therapeutic loading of the gluteal tendons or
strengthening of the kinetic chain (variations of seated gluteal
activation exercises, seated knee extension, and seated calf
raises). Dosage instructions for all exercises reflected those of
the GLoBE program dynamic exercises.
Outcome measures
Outcomes were assessed at baseline, 12, and 52weeks. The
timing of baseline testing varied from the original protocol—
baseline outcome measures were collected post randomization.
The primary outcome measure was the VISA-G (Victorian
Institute of Sport-Gluteal tendon) questionnaire,21 a gluteal
tendon outcome measure that quantifies pain with tendon
loading, with a higher score representing less pain and dys-
function. This questionnaire contains a visual analog score for
‘‘usual’’ pain, four questions related to pain, one question
related to difficulty with moving after sitting, and two activity
related questions. A further five questionnaires were used as
FIG. 1. GLoBE exercise
program stages 1–4: (a) hip
hitch; (b) double leg wall
squat; (c) double leg calf
raises; (d) Hip hitch with toe
tap; (e) sit to stand; (f) calf
raises with toe taps; (g) hip
hitch with hip swing, vertical
red arrow indicates a hip
hitch so that the foot is
*1 cm off the ground, hori-
zontal arrow indicates direc-
tion of hip swing; (h) sit to
stand with split stance;
(i) single leg calf raises;
(j) single leg squat; (k) step
up; (l) single leg calf raise.
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secondary outcome measures to assess hip pain and dys-
function, perceived improvement, and quality of life: Oxford
Hip Score (OHS),22 global rating of change questionnaire (-7
to +7 Likert score), Assessment of Quality of Life (AQoL),
Hip dysfunction andOsteoarthritis Outcome Score (HOOS),23
and the Lateral Hip Pain Questionnaire.24 Participant adher-
ence to the exercise program was assessed using an exercise
diary that was filled out by the participant after each home
exercise session.
In addition, at the 52-week follow-up, participants were
asked a series of questions regarding their pain level (in-
creased, decreased, or no change in pain since the study), and
whether they had undertaken new or continued management
strategies following the 12-week education and exercise
program (injection therapy, surgery, and study exercises).
Success of blinding was assessed at the end of week 1 by
asking participants to indicate which group they believed
they were allocated to.
Sample size
Based on the VISA-G questionnaire,21 using standard devia-
tion (SD) of 13.35 and a mean difference of 10.68, a fully
powered trial would require 52 participants (26 per group) to
detect amoderate standardizedmeandifferenceof0.8 (assuming
80% power, an alpha level of 0.05, and a 15% dropout rate).21,25
Statistical analysis
Statistical analysis was undertaken using statistical soft-
ware (SPSS version 21, IBM SPSS, Inc., Chicago, IL), and
intention to treat principles, per-protocol analysis, and re-
sponder analysis were applied. A linear mixed model was
undertaken on dependent variables (questionnaires), adjust-
ing for baseline values and for intention to treat and per-
protocol analyses. If age, height, mass, or body mass index
(BMI) was significantly different between groups, measured
using independent t-tests, they were included as covariates in
the analyses. This was to determine the difference between
and within groups for primary and secondary outcomes. A
responder analysis, adjusting for covariates of BMI and
baseline scores, was undertaken to determine if significant
differences in patient reported outcome measure scores ex-
isted between groups of responders. Participants who reported
a global rating of change of +5 or more at the 12-month time
point were considered ‘‘responders,’’ and the relative risk of
FIG. 2. Sham exercise
program stages 1–4: (a) se-
ated gluteal squeezes; (b)
quadriceps over fulcrum; (c)
seated single leg calf raises;
(d) seated hip abduction; (e)
seated knee extension no re-
sistance; (f) seated double
leg calf raises; (g) standing
lateral flexion; (h) seated
knee extension with red
Theraband resistance; (i) se-
ated calf raise with toe taps;
(j) standing lateral flexion;
(k) seated knee extension
with green Theraband resis-
tance; (l) double leg calf raise
with pulses up and down.
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responding to treatment was calculated. Categorical out-
comes (continuation of exercises, pain level, injection ther-
apy, and hip surgical intervention) at the 52-week time point
were compared using a chi square test, and where the ex-
pected count was less than five in more than 20% of cells, the
Fisher’s exact test score was recorded.
To establish the magnitude of differences, effect sizes were
calculated for each group comparison using standardized
mean differences (SMDs) and 95% confidence intervals
(CIs).26 An effect size threshold of 0.2, 0.5, and 0.8 was
considered small, medium, and large, respectively.27 Global
rating of change scores across groups was compared using a
Mann–Whitney U test. Baseline participant characteristics
were analyzed using independent samples t-tests, and cate-
gorical data were analyzed using chi squared. The effec-
tiveness of blinding was recorded as the total number of the
cohort that remained unaware of their group allocation at the
end of week 1, and participant adherence was calculated as a
percentage of completed exercise sessions.
Results
BetweenMarch 2013 and September 2014, 178womenwere
screened, 94 met the selection criteria and were invited to
participate in the study, and 94 consented to participate (Fig. 3).
Forty-six participants were randomized to the GLoBE inter-
vention exercise program and 48 to the sham exercise program.
The trialwas completed inDecember 2016, 52weeks after the
completion of the last participant’s 12-weekexercise program.A
total of 13 participants withdrew from the study (8 in GLoBE
group and 5 in sham group), and 86.6% were followed up at 12
weeks and at 52 weeks. At the end of week 1, all participants in
the GLoBE and sham groups remained blinded. No participant
was awareof thegroupallocationand reportedbeing ‘‘unsure’’ if
they were in the intervention or sham group. The sham exercise
group was significantly heavier in weight and BMI at baseline
(Table 1). At week 12, only half of theGLoBE participants were
able to progress to stage 4 of the program.
Intention to treat analysis: Treatment effectiveness
for the primary outcome measure, the VISA-G,
and for secondary outcome measures,
the HOOS, OHS, and AQoL
Ten participants had baseline scores brought forward to their
12- and 52-week follow-up for intention to treat analysis. Four
participants (GLoBE· 3, sham· 1) withdrew after randomi-
zation and before completing baseline scores and were ex-
cluded from the analysis.28 Results were adjusted for baseline
questionnaire scores and BMI (Table 1). No between-group
differences were identified for primary and secondary outcome
measures at 12 and 52 weeks. Significant improvements in
outcomes were identified for both groups at the 12- and 52-
week time points, with the exception of the lateral hip pain
questionnaire (LHPQ) sports subsection (Table 2).
Per protocol analysis: Treatment effectiveness
for the primary outcome measure, the VISA-G
and for secondary outcome measures, the HOOS,
OHS, and AQoL
In total, 38 GLoBE participants and 43 Sham participants
were included in the analysis. No between-group differences
were identified for the VISA-G, HOOS, OHS, and AQoL
questionnaires for either protocol. Significant improvements
in outcomes ( p< 0.01) were found for both GLoBE and sham
interventions from baseline to 12- and 52-week time points
for all outcomes except the sports subsection on the LHPQ
(12-week follow-up for both groups and 52-week follow-up
for GLoBE group) (Appendix 1).
Treatment effectiveness: self-reported measure,
the Global Rating of Change
GLoBE participants reported being ‘‘quite a bit better’’
(median [interquartile range]: 5.0 [2.0–7.0]) and sham group,
‘‘moderately better’’ 4.0 (2.0–7.0) at 12 weeks. At the 52-
week follow-up both groups reported being ‘‘quite a bit
better’’ (GLoBE: 5.0 [0.5–7.0] and sham: 5.0 [0.75–7.0]).
There was no significant between-group difference in global
rating of change score at 12-week ( p= 0.340) and 52-week
( p= 0.746) time points. There was no significant difference
between groups in the number of responders (GLoBE, 20/37;
sham, 24/43; relative risk [CI] = 0.969 [0.650–1.443]).
Responder analysis: Treatment effectiveness
for the primary outcome measure, the VISA-G,
and for secondary outcome measures, the HOOS,
OHS, and AQoL
A responder analysis was performed for participants re-
porting a global rating of change of +5 or more (Table 3).
Significant between-group differences favoring the GLoBE
intervention were identified for all outcomes at the 12-week
(moderate-to-large effects, 0.5–1.0) and 52-week (low-to-
moderate effects, 0.2–0.7) follow-up, except the lateral hip
pain questionnaire sports subsection at 12 weeks and AQoL
at all time points. Significant within-group differences were
found for the GLoBE intervention for all outcomes except the
lateral hip pain questionnaire sports subsection at 12 and 52
weeks. Significant within-group differences were also found
for the sham intervention, except for the lateral hip pain
questionnaire at the 52-week time point.
Fifty two-week variables
No differences in 52-week variables of pain level, meno-
pausal hormone therapy use, surgical intervention, injection
therapy, or continuation of research study exercises were
found between the groups (Table 4).
Adverse events
During the study, two participants reported increasing lateral
hip pain that did not ease during the 12-week intervention
period (one participant from each group). One reported that her
increase in pain was attributed to the exercises, and the other
attributed her lateral hip pain from a sudden increase in activity
levels while travelling overseas. Despite this, both completed
the program, and 12- and 52-week outcome measures were
collected and included in the analysis.
Participant adherence
There was no significant difference in adherence levels
between groups over the 12-week period ( p = 0.97). The
mean percentage of exercise completion for GLoBE exercise
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FIG. 3. Flow of participants throughout the study.
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group was 75.80% (SD= 23.49) and sham exercise group was
75.99% (SD = 25.35). Similarly, both groups completed their
morning and evening exercises to an equivalent level, with no
significant differences identified: morning exercises GLoBE
79.35% (SD = 21.33), sham 85.3% (SD = 16.61) p = 0.96;
evening exercises GLoBE 76.1% (SD = 23.7), sham 81.6%
(SD = 17.2), p = 1.00.
Discussion
Significant within-group improvements in pain, function,
and quality of life measures were identified for both GLoBE
and sham interventions from baseline to 12 and 52 weeks;
however, the type of exercise intervention did not affect
results.
Within-group improvements for both GLoBE and sham
interventions in all analyses may reflect the importance of
education in the management of GTPS. Education was con-
sistent between groups and focused on decreasing compression
of the gluteal tendons over the greater trochanter. Mechanical
compression has been reported to cause adaptive changes in
tendon with the formation of fibrocartilage, increased pro-
teoglycan production,29 and increased cross-sectional area.30
Similarly, compressive and tensile load, in isolation, but
more importantly in combination, can have negative impli-
cations for pathology resulting in pain31 and dysfunction.
Thus, a reduction in these loads should result in pain relief
and increased function.
No studies have evaluated the benefits of an education
program in the management of GTPS. However, education to
avoid aggravating activities has been recommended as a
management strategy for the condition32 and is being used in
ongoing RCTs.19,33 Education principles were discussed with
each participant andwere applied to their specific activities of
daily living, sport, and recreation. This may have enabled
easy translation and uptake of these strategies and contrib-
uted to a reduction in pain and symptoms. Education and
advice on activities of daily living may have provided this
group of postmenopausal women with enough pain relief to
undertake activities at a sufficient level of function and im-
prove quality of life (AQoL). However, it remains unclear if
these improvements were solely due to the education, whe-
ther in fact the sham exercises contributed to this improve-
ment or it was improvement over time, regardless of
intervention. Without a wait-and-see group the influence of
time cannot be estimated; however, since almost half the
cohort were no better (no change in pain) at 52 weeks, the
impact of time may not be particularly relevant in this pop-
ulation. This reflects the chronic recalcitrant nature of the
condition. Thus, it is likely that the education underpinned
the improvements that were seen, rather than this being due to
the natural recovery of the condition. This is especially true in
GTPS where simple lifestyle amendments can impact on
pain, perhaps more so than other conditions such as hip OA.
Future research could involve a comparison with an educa-
tion only group and/or a change over time group.
The effect of placebo on significant within-group changes
cannot be underestimated. It has been found that open-label
placebo treatment reduces pain and disability in chronic low-
back pain sufferers, compared to usual treatment over a 3-
week period.34 Although GTPS participants were blinded to
group allocation in this study, they were made aware of the
potential to receive an exercise program not targeting reha-
bilitation of GTPS alongside education. Furthermore, both
interventions were delivered by a qualified physiotherapist in
a clinical setting, with equal enthusiasm for the program.
The primary structure contributing to nociceptive input
could alter the response to exercise intervention. Since the
cause of tendon pain is not known35 and the pathophysiology
of GTPS is poorly understood, it is plausible that responders
in the GLoBE group had primary tendon pathology known to
benefit from isometric exercise.17 Comorbidities in other
structures around the hip (e.g., labral tear, chondropathy)
could impact on the response to the exercise programs. Re-
sponders to the GLoBE exercise and education program had
significantly greater improvements in their outcome mea-
sures compared with the responders in the sham exercise and
education program. This may indicate that there is a subgroup
of people with GTPS who respond better (improved pain and
function) to a GLoBE exercise program with education than
with a sham exercise program with education. Further anal-
ysis of subgroup characteristics using the current data was not
undertaken since adequately powered responder analysis
requires a greater sample size to allow for dichotomizing
continuous variables and to identify characteristics of sub-
groups.36,37 Heterogeneity within a group of participants can
diminish the likelihood of significant treatment effects38 as
only a certain proportion of the group will be responsive
to the given treatment intervention. This has been shown in
low-back pain disorders39 and patellofemoral joint pain40
whereby targeted interventions for subgroups have been ef-
fective in reducing pain and dysfunction and recommended
in hip chondropathy studies.41 With adequate power for
subgroup analysis, the level of pain and disability at baseline,
personal, and pathophysiological factors could be examined
to determine likely responsiveness to treatment intervention.
The GLoBE exercise intervention was designed with the
intention to load the gluteal tendons in functional positions
without causing compression. Interestingly, only two par-
ticipants in the GLoBE exercise program were unable to
complete the hip hitch exercise at the first appointment due to
increased lateral hip pain and instead were prescribed an al-
ternative bilateral standing isometric abduction exercise until
they were able to resume the GLoBE intervention protocol.
This indicates that the majority of postmenopausal women
with GTPS can tolerate standing isometric hip exercises at
first presentation.
Table 1. Characteristics
Baseline variables
GLoBE
(n = 46)
Sham
(n= 48)
pMean (SD) Mean (SD)
Age 61.14 (6.70) 62.53 (8.92) 0.771
Height 164.40 (6.10) 163.09 (6.60) 0.415
Mass 71.83 (12.80) 81.92 (20.04) 0.006
BMI 26.57 (4.69) 30.83 (7.18) 0.002
VISA-G Score 61.60 (10.91) 53.83 (17.33) 0.018
Side affected
(left/right)
23/20 25/22 0.803a
aChi squared test.
BMI, body mass index; SD, standard deviation; n, number
included in analysis; Bold, significant finding.
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Limitations
No guidelines exist on the most effective exercises for
gluteal tendon rehabilitation, with only one published article
in this area.12 However, the prescription of exercises in this
study was based on clinical expertise and prior electromyo-
graphic studies.42 Sham exercises were chosen based on their
perceived inability to load the tendon; however, biome-
chanical and electromyographic analysis has not been un-
dertaken on these exercises.
This study used patient-reported outcome measures to
determine changes in hip pain and function at 12 and 52
weeks following the intervention. For a more thorough
evaluation of the effects of each individual program, physical
outcome measures (muscle strength and objective functional
tests) may be considered important to investigate the speci-
ficity required in therapeutic exercise and also provide di-
rection for mechanistic studies. Similarly, it would have been
beneficial to collect data on participation in sport, physical
activity, and duration of GTPS symptoms, to detect the
benefits of each exercise program in particular subgroups.
Results did not control for medication use (therapeutic or
medicinal), but randomization may account for this potential
confounder.
Due to the pragmatic nature of the study, it was more cost
effective and time efficient to collect baseline data at the first
physiotherapy appointment, rather than before randomization
as outlined in the protocol.19 Consequently, baseline mea-
sures were not received for four participants, and these par-
ticipants were excluded from the intention to treat analysis.
The use of 23 physiotherapists to implement the inter-
vention made it difficult to ensure that each clinician adhered
to the exercise protocol, potentially affecting results. How-
ever, auditing clinical notes, standardized training, and pre-
scription of exercises based on provided booklets aimed to
ensure consistent treatment administration.
Future research
This single-arm trial may indicate that education is largely
responsible for within-group changes; however, a wait and
see approach is required to assess whether improvements in
both groups are attributable to the natural history of the
condition. A subgroup of participants in the study further
responded to GLoBE exercise therapy in addition to educa-
tion. Research to identify these patients would assist clini-
cians to implement appropriate management strategies for
individual rehabilitation. It is possible that there are exer-
cises, not yet researched, that are more effective at reducing
GTPS pain and dysfunction than those identified in this study.
Thus, comparison of the GLoBE exercise program with other
exercise programs is important to consider. Furthermore,
only half of the globe group progressed to the end of the
program by 12weeks. So an analysis of level was reached and
change in pain and function could be investigated.
Conclusion
A lack of treatment effect was foundwith the addition of an
exercise program (GLoBE targeted exercise or sham exer-
cise) to a comprehensive education on GTPS management.
Both groups resulted in improvements at 12 and 52 weeks,
with no significant differences found between groups using
intention to treat analysis. Responders in the GLoBE group
improved to a greater degree than responders in the sham
exercise group. This highlights that diagnostic subgroups
likely exist in GTPS and that further work on the classifica-
tion of GTPS is warranted.
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